94 related articles for article (PubMed ID: 28721010)
1. Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway.
Zhao KH; Zhang C; Bai Y; Li Y; Kang X; Chen JX; Yao K; Jiang T; Zhong XS; Li WB
Drug Des Devel Ther; 2017; 11():1905-1915. PubMed ID: 28721010
[TBL] [Abstract][Full Text] [Related]
2. Effect of gold-conjugated resveratrol nanoparticles on glioma cells and its underlying mechanism.
Liu X; Guo Z; Li J; Wu D; Liu Z; Guan C; Guan Y; Lu X
Biomed Mater Eng; 2024; 35(3):279-292. PubMed ID: 38461500
[TBL] [Abstract][Full Text] [Related]
3. Suppression of PI3K/Akt/mTOR pathway in chrysoeriol-induced apoptosis of rat C6 glioma cells.
Wongkularb S; Limboonreung T; Tuchinda P; Chongthammakun S
In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):29-36. PubMed ID: 34907494
[TBL] [Abstract][Full Text] [Related]
4. DNA polymerase ζ suppresses the radiosensitivity of glioma cells by regulating the PI3K/AKT/mTOR pathway.
Ding J; Chen Z; Ding W; Xiang Y; Yang J
Autoimmunity; 2023 Dec; 56(1):2234101. PubMed ID: 37448296
[TBL] [Abstract][Full Text] [Related]
5. The pseudogene PRELID1P6 promotes glioma progression via the hnHNPH1-Akt/mTOR axis.
Xi S; Cai H; Lu J; Zhang Y; Yu Y; Chen F; Huang Q; Wang F; Chen Z
Oncogene; 2021 Jul; 40(26):4453-4467. PubMed ID: 34108621
[TBL] [Abstract][Full Text] [Related]
6. Targeting RTK-PI3K-mTOR Axis in Gliomas: An Update.
Colardo M; Segatto M; Di Bartolomeo S
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063168
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma.
He C; Xu K; Zhu X; Dunphy PS; Gudenas B; Lin W; Twarog N; Hover LD; Kwon CH; Kasper LH; Zhang J; Li X; Dalton J; Jonchere B; Mercer KS; Currier DG; Caufield W; Wang Y; Xie J; Broniscer A; Wetmore C; Upadhyaya SA; Qaddoumi I; Klimo P; Boop F; Gajjar A; Zhang J; Orr BA; Robinson GW; Monje M; Freeman Iii BB; Roussel MF; Northcott PA; Chen T; Rankovic Z; Wu G; Chiang J; Tinkle CL; Shelat AA; Baker SJ
Nat Commun; 2021 Jul; 12(1):4089. PubMed ID: 34215733
[TBL] [Abstract][Full Text] [Related]
8. Targeting glutaminase and mTOR.
Tanaka K; Sasayama T; Kohmura E
Oncotarget; 2015 Sep; 6(29):26544-5. PubMed ID: 26337208
[No Abstract] [Full Text] [Related]
9. Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
Singh E; Gurses ME; Costello MC; Berke C; Lu VM; Daggubati L; Komotar RJ; Ivan ME; Shah AH
J Neurooncol; 2024 Mar; 167(1):49. PubMed ID: 38446375
[No Abstract] [Full Text] [Related]
10. A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1.
Zhao K; Braun M; Meyer L; Otte K; Raifer H; Helmprobst F; Möschl V; Pagenstecher A; Urban H; Ronellenfitsch MW; Steinbach JP; Pesek J; Watzer B; Nockher WA; Taudte RV; Neubauer A; Nimsky C; Bartsch JW; Rusch T
Cells; 2024 Apr; 13(7):. PubMed ID: 38607071
[TBL] [Abstract][Full Text] [Related]
11. Leptomeningeal neuraxis relapse in glioblastoma is an uncommon but not rare event associated with poor outcome.
Wegener E; Horsley P; Wheeler H; Jayamanne D; Kastelan M; Guo L; Brown C; Back M
BMC Neurol; 2023 Sep; 23(1):328. PubMed ID: 37715122
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal methotrexate in combination with systemic chemotherapy in glioblastoma patients with leptomeningeal dissemination: A retrospective analysis.
Kang X; Chen F; Yang SB; Wang YL; Qian ZH; Li Y; Lin H; Li P; Peng YC; Wang XM; Li WB
World J Clin Cases; 2022 Jun; 10(17):5595-5605. PubMed ID: 35979103
[TBL] [Abstract][Full Text] [Related]
13. Leptomeningeal Spread at the Diagnosis of Glioblastoma Multiforme: A Case Report and Literature Review.
Jang C; Cho BK; Hwang SH; Shin HJ; Yoon SH
Brain Tumor Res Treat; 2022 Jul; 10(3):183-189. PubMed ID: 35929116
[TBL] [Abstract][Full Text] [Related]
14. Study on the molecular mechanism of nightshade in the treatment of colon cancer.
Na S; Ying L; Jun C; Ya X; Suifeng Z; Yuxi H; Jing W; Zonglang L; Xiaojun Y; Yue W
Bioengineered; 2022 Jan; 13(1):1575-1589. PubMed ID: 35012428
[TBL] [Abstract][Full Text] [Related]
15. Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma.
Kim DY; Nam J; Chung JS; Kim SW; Shin HJ
Cancer Res Treat; 2022 Jan; 54(1):301-313. PubMed ID: 33940789
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of hsa_circ_0004543 Activates oxLDL-Induced Vascular Endothelial Cell Proliferation and Angiogenesis.
Han L; Li D; Hang Y; Zong X; Lv J; Bai X; Lu Y; Zhang P; Zhou M; Wu Z; Hu W
Front Genet; 2021; 12():632164. PubMed ID: 33841499
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.
Birzu C; Tran S; Bielle F; Touat M; Mokhtari K; Younan N; Psimaras D; Hoang-Xuan K; Sanson M; Delattre JY; Idbaih A
Oncologist; 2020 Nov; 25(11):e1763-e1776. PubMed ID: 33394574
[TBL] [Abstract][Full Text] [Related]
18. Demethoxycurcumin analogue DMC-BH exhibits potent anticancer effects on orthotopic glioblastomas.
Shi L; Sun G; Zhang Y
Aging (Albany NY); 2020 Nov; 12(23):23795-23807. PubMed ID: 33221748
[TBL] [Abstract][Full Text] [Related]
19. The Gαh/phospholipase C-δ1 interaction promotes autophagosome degradation by activating the Akt/mTORC1 pathway in metastatic triple-negative breast cancer.
Lin HY; Kuei CH; Lee HH; Lin CH; Zheng JQ; Chiu HW; Chen CL; Lin YF
Aging (Albany NY); 2020 Jul; 12(13):13023-13037. PubMed ID: 32615541
[TBL] [Abstract][Full Text] [Related]
20. IMPA2 Downregulation Enhances mTORC1 Activity and Restrains Autophagy Initiation in Metastatic Clear Cell Renal Cell Carcinoma.
Kuei CH; Lin HY; Lee HH; Lin CH; Zheng JQ; Chen KC; Lin YF
J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32235551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
